Treatment of Facial Flushing With Botulinum Toxin A Injections
Treatment of Facial Flushing With Botulinum Toxin A Injections: A Split-Face, Double-blinded, Randomized Control Trial
Sponsor: Northwestern University
This PHASE4 trial investigates Facial Flushing and is currently ongoing. Northwestern University leads this study, which shows 15 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
15 versions recorded-
Jun 2025 — Present [monthly]
Active Not Recruiting PHASE4
-
Feb 2025 — Jun 2025 [monthly]
Active Not Recruiting PHASE4
Phase: NA → PHASE4
-
Sep 2024 — Feb 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
▶ Show 10 earlier versions
-
Mar 2023 — Apr 2024 [monthly]
Active Not Recruiting NA
-
Feb 2022 — Mar 2023 [monthly]
Active Not Recruiting NA
-
Jan 2022 — Feb 2022 [monthly]
Active Not Recruiting NA
-
Feb 2021 — Jan 2022 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting NA
-
Mar 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Mar 2019 — Mar 2020 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Mar 2019 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Aug 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Northwestern University
For direct contact, visit the study record on ClinicalTrials.gov .